Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999

2002

Kumar, 2004, Recent developments in fetal medicine, BMJ, 328, 1002, 10.1136/bmj.328.7446.1002

Dolk, 1990, The Prevalence at birth of Down syndrome in 19 regions of Europe 1980-86, 3

Prioux, 2005, Late fertility in Europe: some comparative and historical data, Rev Epidemiol Sante Publique, 53, 2S3, 10.1016/S0398-7620(05)84763-7

Doria-Rose, 2003, Parity and the risk of Down's syndrome, Am J Epidemiol, 158, 503, 10.1093/aje/kwg193

Hook, 1980, Down syndrome frequency in human populations and factors pertinent to variation in rates, 3

Morris, 2002, Revised estimates of the maternal age specific live birth prevalence of Down's syndrome, Journal of Medical Screening, 9, 2, 10.1136/jms.9.1.2

Morris, 2003, Comparison of models of maternal age-specific risk for Down syndrome live births, Prenatal Diagnosis, 23, 252, 10.1002/pd.568

Morris, 1999, Fetal loss in Down syndrome pregnancies, Prenatal Diagnosis, 19, 142, 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7

Snijders, 1995, Maternal age and gestational age specific risk for chromosomal defects, Fetal Diagn Ther, 10, 356, 10.1159/000264259

1994, Variation in prenatal cytogenetic diagnosis: policies in 13 European Countries. 1989-91, Prenatal Diagnosis, 14, 337, 10.1002/pd.1970140504

Garne, 2004, Prenatal diagnostic procedures used in pregnancies with congenital malformations in 14 registries in Europe, Prenatal Diagnosis, 11, 908, 10.1002/pd.1044

Wald, 2003, Antenatal screening for Down's syndrome with the quadruple test, Lancet, 361, 794, 10.1016/S0140-6736(03)12680-3

Nicolaides, 1992, Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy, BMJ, 304, 967, 10.1136/bmj.304.6831.867

De Vigan C, Baena N, Cariati E, Clementi M, Stoll C and the EUROSCAN Working Group. Contribution of ultrasonographic examination to the prenatal detection of chromosomal abnormalities in 19 centres across Europe. Annales de Génétique 2001 44: 209-17.

Koshnood, 2004, A population-based evaluation of the impact of antenatal screening for Down's Syndrome in France, 1981-2000, BJOG, 111, 485, 10.1111/j.1471-0528.2004.00117.x

EUROCAT Special Report. Prenatal Screening Policies in Europe. http://www.eurocat.ulster.ac.uk/pubdata/Publications.html.

Ford, 1998, The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population, Br J Obstet Gynaecol, 105, 855, 10.1111/j.1471-0528.1998.tb10229.x

Sjogren, 1988, Decision making during the prenatal diagnostic procedure. A questionnaire and interview study of 211 women participating in prenatal diagnosis, Prenatal Diagnosis, 8, 263, 10.1002/pd.1970080404

Smith, 1994, Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice, BMJ, 309, 776, 10.1136/bmj.309.6957.776